Check out these photos from today’s Paragraph IV Disputes Conference. www.AmericanConference.com/PIVDisputes
American Conference Institute (ACI) is pleased to announce that Debra Condino, Senior Vice President Chief Intellectual Property Counsel, Allergan, Inc.; Brian Hirsch, Head, US Patent Litigation, Sandoz Inc.; and Staci Julie, SVP and Chief IP Counsel, Teva Pharmaceuticals have joined ACI’s Hatch-Waxman Advisory Board and will speak at ACI’s 10th Annual Paragraph IV Disputes conference…
It is our pleasure to share these slides from the April 2015 conference with you. They cover key and evolving topics that we will continue to explore in 2016: http://hatch-waxmanevents.com/resources.html
Check out all of the highlights from ACI’s 9th Annual Paragraph IV Disputes
September was a productive month for ACI’s conference attendees. At our events, decision makers had the chance to acquire top notch industry information; ranging from the latest trends, developments, hottest litigation cases to key insights from leading experts and more. You now have the opportunity to remain ahead of the curve too by accessing conference materials.…
Expert article by Joseph E. Cwik on May 27, 2014. Originally published on Healthcare Law Insights, reposted with the permission of Joseph E. Cwik. Several parts of the America Invents Act (the “AIA”) became law on Sept. 16, 2012, sparking some of the most meaningful changes to patent law seen in decades. One hot provision…
Expert article by Joseph E. Cwik and Josh Nosal on July 2, 2014. Originally published on Healthcare Law Insights, reposted with the permission of Joseph E. Cwik. The Patent Trial and Appeal Board (PTAB) issued its first final written decisions June 20, 2014, in four inter partes reviews (IPR) of pharmaceutical-related patents. The four decisions…
June was a productive month for ACI’s conference attendees. At our events, decision makers had the chance to acquire top notch industry information; ranging from the latest trends, developments, hottest litigation cases to key insights from leading experts and more. You now have the opportunity to remain ahead of the curve too by accessing conference materials.…
Pharma & Healthcare – the latest on FDA’s proposed generic drug labeling rule, FDA bans imports from India’s Sun Pharma and more.